Indefinite- lived intangible impairment
Xylem Indefinite- lived intangible impairment decreased by 0.2% to $3.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $3.68B to $3.75B. Over 5 years (FY 2020 to FY 2025), Indefinite- lived intangible impairment shows an upward trend with a 13.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in impairment charges signals a decline in the value of the company's intangible assets, potentially indicating poor acquisition outcomes or changing market conditions.
Detailed definition
This represents the gross value of indefinite-lived intangible assets, excluding goodwill, that have been subject to imp...
Peer comparison
Varies significantly based on M&A history; companies with frequent acquisitions often show higher volatility in this metric.
other_intangible_assets_gross_excluding_goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00B | $2.01B | $2.01B | $2.02B | $1.96B | $1.73B | $1.77B | $1.79B | $4.12B | $4.03B | $3.62B | $3.60B | $3.57B | $3.57B | $3.65B | $3.68B | $3.81B | $3.81B | $3.76B | $3.75B |
| QoQ Change | — | +0.1% | +0.1% | +0.7% | -3.0% | -11.6% | +2.1% | +1.3% | +129.6% | -2.0% | -10.3% | -0.4% | -0.7% | -0.1% | +2.1% | +1.0% | +3.4% | +0.1% | -1.4% | -0.2% |
| YoY Change | — | — | — | — | -2.1% | -13.6% | -11.8% | -11.3% | +110.1% | +132.8% | +104.4% | +100.8% | -13.2% | -11.5% | +0.8% | +2.3% | +6.5% | +6.7% | +3.1% | +1.8% |
Indefinite- lived intangible impairment at Other Companies
Frequently Asked Questions
- What is Xylem's indefinite- lived intangible impairment?
- Xylem (XYL) reported indefinite- lived intangible impairment of $3.75B in Q1 2026.
- How has Xylem's indefinite- lived intangible impairment changed year-over-year?
- Xylem's indefinite- lived intangible impairment increased by 1.8% year-over-year, from $3.68B to $3.75B.
- What is the long-term trend for Xylem's indefinite- lived intangible impairment?
- Over 5 years (2020 to 2025), Xylem's indefinite- lived intangible impairment has grown at a 13.7% compound annual growth rate (CAGR), from $1.98B to $3.76B.
- What does indefinite- lived intangible impairment mean?
- The total value of non-goodwill intangible assets that have been written down due to a loss in value.